Page last updated: 2024-09-02

hydroxycotinine and Neoplasms

hydroxycotinine has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Flitter, A; Lerman, C; Schnoll, RA; Siegel, SD	1

Reviews

1 review(s) available for hydroxycotinine and Neoplasms

Article	Year
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3 Topics: Biomarkers; Cost-Benefit Analysis; Cotinine; Cytochrome P-450 CYP2A6; Electronic Nicotine Delivery Systems; Genetic Testing; Genetic Variation; Humans; Implementation Science; Metabolic Clearance Rate; Neoplasms; Nicotine; Precision Medicine; Prevalence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices	2020

Article

Year

The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.

Cancer prevention research (Philadelphia, Pa.), 2020, Volume: 13, Issue:3

Topics: Biomarkers; Cost-Benefit Analysis; Cotinine; Cytochrome P-450 CYP2A6; Electronic Nicotine Delivery Systems; Genetic Testing; Genetic Variation; Humans; Implementation Science; Metabolic Clearance Rate; Neoplasms; Nicotine; Precision Medicine; Prevalence; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices

2020